{"title":"Chapter 2: HIV testing and diagnosis","nid":648,"vid":2837,"created":1633436706,"changed":1636974975,"field_accordian_header":[{"field_accordian":[{"field_title":"Facility-based HIV testing services","field_content":"<p><strong>High-HIV-burden settings<\/strong><\/p>\r\n\r\n<p>HIV testing should be offered to all populations and in all services (for example, services for sexually transmitted infections, hepatitis, TB, children under five, immunization, malnutrition, antenatal care and all services for key populations) as an efficient and effective way to identify people with HIV.<\/p>\r\n\r\n<p><strong>Low-HIV-burden settings<\/strong><\/p>\r\n\r\n<p>HIV testing should be offered for:<\/p>\r\n\r\n<ul>\r\n\t<li>adults, adolescents or children who present in clinical settings with signs and symptoms or medical conditions that could indicate HIV infection, including TB, viral hepatitis and sexually transmitted infections;<\/li>\r\n\t<li>HIV-exposed children and symptomatic infants and children;<\/li>\r\n\t<li>key populations and their partners; and<\/li>\r\n\t<li>all pregnant women.<\/li>\r\n<\/ul>\r\n","field_icon":null},{"field_title":"Facility-based HIV testing services for infants and children","field_content":"<p><strong>High-HIV-burden settings<\/strong><\/p>\r\n\r\n<p>In settings with a high burden of HIV infection, infants and children with unknown HIV status who are admitted for inpatient care or attending malnutrition clinics should be routinely tested for HIV <em>(strong recommendation, lowcertainty evidence)<\/em>.<\/p>\r\n\r\n<p>In settings with a high burden of HIV infection, infants and children with unknown HIV status should be offered HIV testing in outpatient or immunization clinics <em>(conditional recommendation, low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p><strong>Good practice statement<\/strong><\/p>\r\n\r\n<p>In all settings, the biological children of a parent living with HIV (or who may have died from HIV) should be routinely offered HIV testing services and, if found to be either infected or at high risk of infection through breastfeeding, should be linked to services for treatment or prevention and offered a broader package of voluntary provider-assisted referral.<\/p>\r\n","field_icon":null},{"field_title":"Community-based HIV testing services","field_content":"<p><strong>High-HIV-burden settings<\/strong><\/p>\r\n\r\n<p>Community-based HIV testing services are recommended, with linkage to prevention, treatment and care services, in addition to routine facility-based testing, for all populations, particularly key populations <em>(strong recommendation, low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Community-based HIV testing services are recommended for key populations, with linkage to prevention, treatment and care services, in addition to routine facility-based testing <em>(strong recommendation, low-certainty evidence)<\/em>.<\/p>\r\n","field_icon":null},{"field_title":"HIV self-testing","field_content":"<p>HIV self-testing should be offered as an approach to HIV testing <em>(strong recommendation, moderate-certainty evidence)<\/em>.<\/p>\r\n\r\n<p><strong>Remarks<\/strong><\/p>\r\n\r\n<ul>\r\n\t<li>Providing HIV self-testing service delivery and support options is desirable.<\/li>\r\n\t<li>Communities need to be engaged in developing and adapting HIV self-testing models.<\/li>\r\n\t<li>HIV self-testing does not provide a definitive HIV-positive diagnosis. Individuals with a reactive test result must receive further testing from a trained tester using the national testing algorithm.<\/li>\r\n<\/ul>\r\n","field_icon":null},{"field_title":"HIV partner services","field_content":"<p>Provider-assisted referral should be offered to people with HIV as part of a comprehensive package of testing and care <em>(strong recommendation, moderate-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Social network\u2013based approaches can be offered as an HIV testing approach for key populations as part of a comprehensive package of care and prevention <em>(conditional recommendation, very-low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p><strong>Good practice statement<\/strong><\/p>\r\n\r\n<p>In all settings, biological children with a parent living with HIV (or who may have died from HIV) should be routinely offered HIV testing services and, if found to be either infected or at high risk of infection through breastfeeding, should be linked to services for treatment or prevention and offered a broader package of voluntary provider-assisted referral.<\/p>\r\n\r\n<p><em>Note: Partner services include partner notification, contact tracing, index testing and family-based index case testing for reaching the partners of people living with HIV. These guidelines define partner services as encompassing a range of partner services packages and approaches, including social network\u2013based approaches.<\/em><\/p>\r\n","field_icon":null}],"field_header":"HIV testing service delivery approaches"},{"field_accordian":[{"field_title":"Infants and children","field_content":"<p>Addition of nucleic acid testing (NAT) at birth to existing early infant diagnosis testing approaches can be considered to identify HIV infection among HIV-exposed infants <em>(conditional recommendation, low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>In settings with a high burden of HIV infection, infants and children with unknown HIV status who are admitted for inpatient care or attending malnutrition clinics should be routinely tested for HIV <em>(strong recommendation, lowcertainty evidence)<\/em>.<\/p>\r\n\r\n<p>In settings with a high burden of HIV infection, infants and children with unknown HIV status should be offered HIV testing in outpatient or immunization clinics <em>(conditional recommendation, low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Point-of-care nucleic acid testing should be used to diagnose HIV among infants and children younger than 18 months of age <em>(strong recommendation, high-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Rapid diagnostic tests for HIV serology can be used to assess HIV exposure among infants younger than four months of age. HIV-exposure status among infants and children 4\u201318 months of age should therefore be ascertained by HIV serological testing the mother <em>(conditional recommendation, low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Rapid diagnostic tests for HIV serology can be used to diagnose HIV infection among children older than 18 months following the national testing strategy <em>(strong recommendation, moderate-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>An indeterminate range of viral copy equivalents should be used to improve the accuracy of all nucleic acid\u2013based early infant diagnosis assays <em>(strong recommendation, moderate-certainty evidence)<\/em>.<\/p>\r\n\r\n<p><strong>Good practice statements<\/strong><\/p>\r\n\r\n<p>National regulatory agencies are encouraged not to delay the adoption of point-of-care early infant diagnosis by conducting further evaluations but instead to adopt a rapid and streamlined registration and national approval process for immediate implementation.<\/p>\r\n\r\n<p>In all settings, biological children with a parent living with HIV (or who may have died of HIV) should be routinely offered HIV testing services and, if found to be either infected or at high risk of infection through breastfeeding, should be linked to services for treatment or prevention and offered a broader package of voluntary provider-assisted referral.<\/p>\r\n","field_icon":null},{"field_title":"Adolescents","field_content":"<p>HIV testing services, with linkages to prevention, treatment and care, are recommended for adolescents from key populations <em>(strong recommendation, very-low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Adolescents should be counselled about the potential benefits and risks of disclosing their HIV-positive status and empowered and supported to determine whether, when, how and to whom to disclose <em>(conditional recommendation, very-low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Settings with a high burden of HIV infection<br \/>\r\nIn settings with a high burden of HIV infection, HIV testing services, with linkage to prevention, treatment and care, are recommended for all adolescents <em>(strong recommendation, very-low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Settings with a low burden of<br \/>\r\nHIV infection HIV testing services, with linkage to prevention, treatment and care, should be accessible to adolescents in low and concentrated epidemics\u1d43 (conditional recommendation, very-low-certainty evidence).<br \/>\r\n<br \/>\r\n\u1d43 Now referred to as settings with a low burden of HIV infection.<\/p>\r\n","field_icon":null},{"field_title":"Infants and children","field_content":"<p>HIV testing services should be routinely offered to all key populations both in the community and in facility-based settings. Community-based HIV testing, with linkage to prevention, treatment and care, should be offered, in addition to routinely offering testing in facilities, for key populations in all settings <em>(strong recommendation, low-certainty evidence).<\/em><\/p>\r\n\r\n<p>Social network\u2013based approaches can be offered as an HIV testing approach for key populations as part of a comprehensive package of care and prevention <em>(conditional recommendation, very-low-certainty evidence).<\/em><\/p>\r\n","field_icon":null},{"field_title":"Pregnant women, couples and partners ","field_content":"<p>All pregnant women should be tested for HIV, syphilis and hepatitis B surface antigen (HBsAg)\u1d43 at least once and as early as possible (<em>syphilis: strong recommendation, moderate-certainty evidence; HBsAg\u1d43 : strong recommendation, low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Dual HIV and syphilis rapid diagnostic tests can be the first test in HIV testing strategies and algorithms in antenatal care.<\/p>\r\n\r\n<p>\u1d43 Particularly in settings with a \u22652% HBsAg seroprevalence in the general population.<\/p>\r\n\r\n<p>Provider-assisted referral should be offered to all people with HIV as part of a voluntary comprehensive package of testing and care <em>(strong recommendation, moderate-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Couples and partners should be offered voluntary HIV testing services with support for mutual disclosure <em>(strong recommendation, low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>Women who disclose any form of violence by an intimate partner (or other family member) or sexual assault by any perpetrator should be offered immediate support. Health-care providers should, as a minimum, offer first-line support when women disclose violence. If health-care providers are unable to provide first-line support, they should ensure that someone else (within their health-care setting or another that is easily accessible) is immediately available to do so <em>(strong recommendation, indirect evidence)<\/em>.<\/p>\r\n\r\n<p>Health-care providers should ask about exposure to intimate partner violence when assessing conditions that may be caused or complicated by intimate partner violence, to improve diagnosis and identification and subsequent care <em>(strong recommendation, indirect evidence)<\/em>.<\/p>\r\n\r\n<p><strong>Good practice statement<\/strong><\/p>\r\n\r\n<p>Mandatory or coercive testing is never warranted. In consultation with the client, the provider should assess the risk of harm, the most appropriate approach for couple and partner testing, including more supportive options such as provider assistance, and situations that make couple or partner testing inadvisable.<\/p>\r\n","field_icon":null}],"field_header":" Priority populations"},{"field_accordian":[{"field_title":"Task sharing","field_content":"<p>Lay providers who are trained and supervised to use rapid diagnostic tests can independently conduct safe and effective HIV testing services <em>(strong recommendation, moderate-certainty evidence)<\/em>.<\/p>\r\n","field_icon":null}],"field_header":"Strategies to make HIV testing services accessible"},{"field_accordian":[{"field_title":"Western blotting","field_content":"<p>Western blotting and line immunoassays should not be used in national HIV testing strategies and algorithms <em>(strong recommendation, low-certainty evidence)<\/em>.<\/p>\r\n","field_icon":null},{"field_title":"HIV testing strategy and algorithm ","field_content":"<p>WHO recommends that all HIV testing algorithms achieve at least 99% positive predictive value and use a combination of tests with \u226599% sensitivity and \u226598% specificity.<\/p>\r\n\r\n<p>The first test in an HIV testing strategy and algorithm should have the highest sensitivity, followed by a second and third test of the highest specificity.<\/p>\r\n\r\n<p>Countries should consider moving to a three-test strategy as HIV positivity within national HIV testing service programmes falls below 5% \u2013 meaning all people presenting for HIV testing services should have three consecutive reactive test results in order to receive an HIV-positive diagnosis.<\/p>\r\n\r\n<p>Dual HIV\/syphilis rapid diagnostic tests can be the first test in HIV testing strategies and algorithms in antenatal care.<\/p>\r\n\r\n<p>WHO suggests using a testing strategy for HIV diagnosis that is suitable for HIV diagnosis during surveillance and routinely returning HIV test results to participants.<\/p>\r\n","field_icon":null},{"field_title":"Retesting prior to ART initiation","field_content":"<p>All people newly diagnosed with HIV should be retested to verify their HIV status prior to starting ART, using the same testing strategy and algorithm as the original diagnosis.<\/p>\r\n\r\n<p>Retesting among people with HIV who already know their status, including those on treatment, is not recommended as it can provide incorrect results if the person with HIV is on ART.<\/p>\r\n","field_icon":null}],"field_header":"Maintaining the accuracy and reliability of HIV diagnosis"},{"field_accordian":[{"field_title":"infants and children","field_content":"<p><strong>Timing of virological testing<\/strong><\/p>\r\n\r\n<p>The addition of nucleic acid testing (NAT) at birth to existing early infant diagnosis testing approaches can be considered to identify HIV infection in HIV-exposed infants <em>(conditional recommendation, low-certainty evidence)<\/em>.<\/p>\r\n\r\n<p><strong>Technologies to use for infant testing<\/strong><\/p>\r\n\r\n<p>Point-of-care nucleic acid testing should be used to diagnose HIV among infants and children younger than 18 months of age <em>(strong recommendation, high-certainty evidence)<\/em>.<\/p>\r\n\r\n<p><strong>Rapid diagnostic tests for HIV serology<\/strong><\/p>\r\n\r\n<p>Rapid diagnostic tests for HIV serology can be used to assess HIV exposure among infants younger than four months of age. HIV-exposure status among infants and children four to 18 months of age should therefore be ascertained by undertaking HIV serological testing in the mother <em>(conditional recommendation, low-certainty evidence).<\/em><\/p>\r\n\r\n<p>Rapid diagnostic tests for HIV serology can be used to diagnose HIV infection among children older than 18 months following the national testing strategy <em>(strong recommendation, moderate-certainty evidence)<\/em>.<\/p>\r\n\r\n<p><strong>Minimizing false-positive results by introducing an indeterminate range for infant diagnosis when using NAT<\/strong><\/p>\r\n\r\n<p>An indeterminate range\u1d43 of viral copy equivalents should be used to improve the accuracy of all nucleic acid\u2013based early infant diagnosis assays <em>(strong recommendation, moderate-certainty evidence)<\/em>.<\/p>\r\n\r\n<p>\u1d43 Indeterminate range: a range of viral copy equivalents that would be too low to be accurately diagnosed as HIV infected. The indeterminate range suggested is currently estimated to be approximately equivalent to a cycle threshold of 33 on the Roche COBAS\u00ae Ampliprep\/COBAS\u00ae TaqMan\u00ae HIV-1 Qualitative Test v2.0 assay.<\/p>\r\n","field_icon":null}],"field_header":"HIV diagnosis among infants and children"}],"field_content_type":{"tid":8,"name":"Accord","class":"accord"}}